Business Context and Reporting Period
KALA BIO, Inc. (KALA) filed a Form 8-K on November 10, 2025, regarding a regulatory notice from the Nasdaq Stock Market. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market.
Key Financial Metrics and Listing Status
The filing addresses a failure to meet the Nasdaq Listing Rule 5550(b)(2) Minimum Market Value of Listed Securities (MVLS) Requirement. Specifically:
- Market Value Deficiency: The market value of the Company's listed securities was less than $35 million for the previous 30 consecutive business days.
- Alternative Standards: The Company does not meet alternative listing standards, as it lacks stockholders' equity of at least $2.5 million or net income from continued operations of at least $500,000 in the most recently completed fiscal year or two of the three most recently completed fiscal years.
- Financial Data: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity beyond the thresholds mentioned above.
Material Changes and Compliance Timeline
On November 10, 2025, the Company received a deficiency letter from the Nasdaq Listing Qualifications Department. Key timeline details include:
- Compliance Period: The Company has been granted 180 calendar days to regain compliance.
- Compliance Date: May 11, 2026.
- Regaining Compliance: Compliance can be achieved if the market value of listed securities closes at $35 million or more for a minimum of 10 consecutive business days prior to the Compliance Date.
- Consequences of Non-Compliance: Failure to regain compliance by the Compliance Date will result in a delisting notice. The Company may appeal this determination to a Nasdaq Listing Qualifications Panel, though success is not assured.
Outlook and Management Commentary
Management intends to monitor the market value of its listed securities and may consider available options to regain compliance with Nasdaq Listing Rules. The filing explicitly states there can be no assurance that an appeal of a potential delisting determination would be successful.
Investor Verification Checklist
- Verify the current market capitalization and recent trading volume to assess the likelihood of meeting the $35 million threshold within 180 days.
- Review the most recent 10-K or 10-Q filings to confirm the specific stockholders' equity and net income figures cited as failing the alternative standards.
- Monitor for any subsequent announcements regarding capital raising activities, reverse stock splits, or other corporate actions intended to restore listing compliance.
- Assess the potential impact of a delisting on liquidity and the ability to trade on other exchanges.